Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

2Seventy Bio, Inc. (TSVT)

:TSVT

TSVT

2seventy bio

Overview

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

Stock Screener

reports

2seventy bio (TSVT) Price & Analysis

Compare

― Followers

TSVT Stock Chart & Stats

Day’s RangeN/A

52-Week Range― - ―

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

N/A

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

BetaN/A

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

2seventy bio News

2Seventy Bio Reports Strong Q1 2025 Earnings

2Seventy Bio, Inc. ( ($TSVT) ) has released its Q1 earnings. Here is a breakdown of the information...

3M ago

TSVT

2seventy bio Completes Merger, Delists from Nasdaq

2seventy bio ( ($TSVT) ) just unveiled an update. On May 13, 2025, 2seventy bio completed a merger...

3M ago

TSVT

2seventy bio Reports 2024 Earnings Amid BMS Merger

2Seventy Bio, Inc. ( ($TSVT) ) has released its Q4 earnings. Here is a breakdown of the information...

5M ago

TSVT

2seventy Bio reports Q4 EPS (37c) vs ($1.11) last year

Reports Q4 revenue $2.9M, consensus $13.03M. “2024 was a pivotal year for 2seventy as we made significant changes...

5M ago

TSVT

Is TSVT a Buy, Before Earnings?

2Seventy Bio, Inc. (TSVT) is scheduled to report 4th quarter earnings on 03/25/2025. Regarding Q4 estimates, Wall Street...

5M ago

TSVT

2seventy bio Delays Yearly Report Filing

2seventy bio ( ($TSVT) ) has released a notification of late filing. 2seventy bio, Inc. has announced a...

5M ago

TSVT

2seventy Bio price target lowered to $5 from $6 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on 2seventy Bio (TSVT) to $5 from $6 and keeps an...

5M ago

BMY

TSVT

Hold Rating Amidst Favorable Acquisition Terms and Competitive Pressures for 2seventy bio

Vikram Purohit, an analyst from Morgan Stanley, maintained the Hold rating on 2seventy bio (TSVT – Research Report)....

5M ago

TSVT

Spotify upgraded, Freshpet downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

5M ago

BMY

Morning Movers: 2seventy Bio skyrockets following acquisition by Bristol Myers

Stock index futures are edging higher this morning, attempting a modest rebound following the largest one-day decline of...

5M ago

AAL

2seventy Bio downgraded to Market Perform from Outperform at Leerink

Leerink downgraded 2seventy Bio (TSVT) (TVST) to Market Perform from Outperform with a price target of $5, down...

5M ago

BMY

TSVT

2seventy Bio to be acquired by Bristol Myers for $5.00 per share in cash

2seventy Bio (TSVT) announced a definitive merger agreement under which Bristol Myers Squibb (BMY) will acquire all of...

5M ago

BMY

TSVT

2seventy Bio reports preliminary FY25 Abecma revenue $242M

Reports approximately $184M of cash, cash equivalents and marketable securities as of December 31; Net cash burn of...

7M ago

TSVT

Regeneron pays $1M milestone payment to Medigene

Medigene announced a $1M milestone payment from Regeneron (REGN) was triggered. Regeneron purchased the MAGE-A4-TCR program as part...

9M ago

REGN

TSVT

TSVT FAQ

What was 2Seventy Bio, Inc.’s price range in the past 12 months?

Currently, no data Available

What is 2Seventy Bio, Inc.’s market cap?

Currently, no data Available

When is 2Seventy Bio, Inc.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were 2Seventy Bio, Inc.’s earnings last quarter?

Currently, no data Available

Is 2Seventy Bio, Inc. overvalued?

According to Wall Street analysts 2Seventy Bio, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does 2Seventy Bio, Inc. pay dividends?

2Seventy Bio, Inc. does not currently pay dividends.

What is 2Seventy Bio, Inc.’s EPS estimate?

2Seventy Bio, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does 2Seventy Bio, Inc. have?

Currently, no data Available

What happened to 2Seventy Bio, Inc.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of 2Seventy Bio, Inc.?

Currently, no hedge funds are holding shares in TSVT

Company Description

2Seventy Bio, Inc.

2seventy bio (TSVT) is a biotechnology company focused on the development and commercialization of innovative cell therapies for the treatment of cancer. Operating in the biopharmaceutical sector, 2seventy bio is dedicated to advancing its pipeline of autologous and allogeneic therapies to improve the lives of patients with serious and life-threatening oncologic diseases.